Nature of Business (Details) |
6 Months Ended | |||
|---|---|---|---|---|
|
Jun. 30, 2026
USD ($)
|
Dec. 31, 2025
USD ($)
|
Jun. 30, 2025
USD ($)
|
Dec. 31, 2024
USD ($)
|
|
| Nature of Business | ||||
| Number of programs | 2 | |||
| Number of clinical programs (in programs) | 1 | |||
| Accumulated deficit | $ 650,145,000 | $ 639,984,000 | ||
| Cash and cash equivalents | $ 5,016,000 | $ 3,820,000 | $ 13,081,000 | $ 21,338,000 |
| X | ||||||||||
- Definition Represents the number of clinical programs. No definition available.
|
| X | ||||||||||
- Definition Number of programs grouped as asset. No definition available.
|
| X | ||||||||||
- Definition Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of accumulated undistributed earnings (deficit). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|